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Abstract
Background: Ovarian thecoma-fibroma groups (OTFG) are uncommon sex cord-stromal neoplasms. The
objective of the study was to demonstrate clinical and sonographic features of OTFG and compare with
surgical histopathology.
Methods: A total of 61 patients with surgically proven OTFG were enrolled in this retrospective study to
demonstrate its clinical and sonographic features and to compare with pathological findings. Gray scale and
color Doppler sonography were performed presurgically with either transabdominal or transvaginal approach
to image pelvic structures and lesions. The clinical findings and sonographic appearances were compared with
the types of the OTFG tumors based on the histopathological diagnosis.
Results: The mean patient age was 53.57 (range, 26–86) years. There were 63.93% (39/61) patients in
postmenopausal and 63.93% (39/61) patients with no clinical symptoms. Ultrasound findings of OTFG revealed
as solid tumors with a typical feature of well-demarcated hypoechoic masses in 70.49% (43/61), among which
74.41% (32/43) tumors were smaller than 5 cm in diameter. There were 17 mixed echogenic masses with
calcification, hemorrhage, or cyst, among which 70.59% (12/17) lesions were larger than 5 cm in diameter.
Acoustic attenuation of the tumor was presented in 44.26% (27/61) of the cases. Doppler flow signals within
the tumors were found in 20 cases (32.79%), in which 80% (16/20) had minimal or moderate flow signals.
Ascites was detected in 32.79% (20/61) of the cases, Megi’s syndrome was found in 1 case. Final pathology
revealed 41 (67.21%) thecoma-fibromas, 15 (24.59%) fibromas, 4 (6.56%) thecomas and 1 (1.64%) fibrosarcoma.
There were 58 patients underwent cancer antigen 125 (CA125) test, and 20.69% (12/58) showed an elevated
level. The diameter of tumors was found to be significantly correlated with CA125 level (p < 0.01) and the
amount of ascites fluid (p < 0.05).
Conclusions: The typical sonographic features of OTFG include adnexal hypoechoic masses with clear border
and acoustic attenuation as well as minimal Doppler flow signals. All the aforementioned features could make
ultrasound imaging as a assistent tool improve the preoperative diagnostic accuracy.
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Background
Ovarian thecoma-fibroma groups (OTFG) are uncommon
sex cord-stromal neoplasms, constituting 1.0 to 4.0% of all
ovarian tumors [1–4]. Most of them are benign, and often
found in postmenopausal patients [5, 6]. The fibromas are
composed in variable proportion of spindle cells forming
collagen, while thecomas arise from stromal cells which
resemble the perifollicular thecal cells, and occasionally
there are histologic features of both fibroma and thecoma,
giving rise to the term fibrothecoma. According to the
World Health Organization classification of ovarian neo-
plasms, they belong to OTFG neoplasms [5, 7–9]. Plain
Computerized Tomography (CT) scan shows hypodensity
or isodensity of the tumors while contrast enhanced CT
scan mainly shows no enhancement or delayed mild
enhancement. Low signals of the tumors are shown by
T1-weighted and T2-weighted Magnetic Resonance Im-
aging (MRI), slightly enhanced by MRI contrast agent
[10–12]. However, the preoperative diagnostic rate of
OTFG is rather low due to its low incidence, diverse clin-
ical syndromes, and the great differences existing in tumor
size, shape and internal components. It is therefore often
misdiagnosed as uterine myoma. When the tumor size is
large, with ascites or even hydrothorax, and an elevated
cancer antigen 125 (CA125) level, it is probably misdiag-
nosed as malignancy [5]. Proper preoperative diagnosis of
the disease, therefore, has significant implications for clin-
ical treatment. Currently, there is little research investigat-
ing the relationship between ultrasound features and
pathologic features of OTFG. The present study collected
and analyzed the ultrasound features, as well as the
clinical and pathologic findings of OTFG, with the aim
to improve preoperative diagnostic accuracy.
Methods
Clinical data
In this retrospective study, 61 patients with surgically
proven OTFG neoplasms were enrolled from Shanghai
Ruijin Hospital between June 2009 and November 2015.
The clinical information, CA125 test and sonographic
results of the OTFG tumors were analyzed and compare
to pathological findings. The study was approved by the
Ruijin Hospital, Shanghai Jiaotong University School of
Medicine institutional ethics committee with exemption
to obtain informed consent from individual patients.
Ultrasound examination
All 61 patients underwent pre-surgical ultrasound exam-
ination of the pelvis using iU22 and HD11 ultrasound
machines (Philips Health Systems, Bothell, WA, USA)
associated with a 7.0–9.0 MHz transvaginal and a
3.5 MHz transabdominal probes. Ultrasound parameters
were adjusted to optimize the image quality for each pa-
tient. Multi-dimensional and multi-angle real-time scans
were performed to image the uterus, adnex and masses
of their locations, sizes, patterns, echogenic characteris-
tics, color Doppler flow, pelvic effusion, and relationship
with surrounding organs.
Color Doppler flow imaging within each tumor was re-
corded and Doppler signal was scored according to estab-
lished standard by D. Timmerman et al. [13], i.e., Score 1:
no color flow signals detected, Score 2: only minimal color
signals detected, Score 3: moderate color signals displayed
and Score 4: abundant color signals presented. Both grey
scale and Doppler ultrasound images with typical features
were digitally recorded in the hard drive of the system.
The impression and preliminary diagnosis of the ovarian
tumors based on the grey scale and Doppler follow im-
aging was made for each case.
Pathological examination
The surgical pathological specimens were immediately
fixated in 4% formaldehyde and embedded in paraffin.
The sectioned slides were stained with hematoxylin-
eosin (HE) for histopathological assessment using light
microscopes.
Each patient of clinical information, CA125 test and
ultrasound results were analyzed and compared to in-
traoperative findings and final pathological diagnosis.
Statistical analysis
All of the statistical analyses were performed using SPSS
13.0 (SPSS Inc., Chicago, IL, USA). Measurement data
were expressed as mean ± standard deviation (x ± s). T-
test was used for comparing the means of two samples;
χ2 test was used for comparing measurement data; The
Pearson’s Correlation was also performed to show the
relationship among the diameter of tumors and the
CA125 levels and the amount of ascites fluid. Statistical
significance was assumed at a p-value < 0.05.
Results
Clinical information
The mean ± SD age of 61 patients was 53.57 (±15.52;
range, 26–86) years. There were 65.57% (40/61) patients
over 50 years old and 63.93% (39/61) in postmenopausal.
Among the 61 patients, the neoplasms were discovered
by routing physical exam in 39 (63.93%) cases and hos-
pital visiting for abdominal pain or bulge in 16 (26.23%)
cases, for menstrual disorders in 4 (6.56%) cases and
for postmenopausal bleeding in 2 (3.28%) cases.
Among 58 of 61 patients who underwent CA125 test,
12 (20.69%) patients showed increase value with a mean
of 166.67 U/ml ranged from 37.6 U/ml to 456.2U/ml
(Normal Value: <35U/ml). In the 12 cases showing an
elevated level of CA125, 91.67% (11/12) had a diameter
of the tumor greater than 5 cm. By Pearson’s Correl-
ation analysis, there was a statistically significant
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correlation between the diameter of tumors and CA125
level (r = 0.64, p < 0.01).
Ultrasound findings
Sonographic findings of the neoplasms in 61 patients
were presented in Table 1 and Figs. 1 (a, b), 2 (a) and
3 (a). The typical sonographic feature of the OTFG was
well-demarcated hypoechoic mass with smooth and
clear margin in 70.49% (43/61). The mean diameter of
the tumor was 5.86 cm, ranging from 1 ~ 25 cm, Based
on preoperative ultrasound features, specific diagnosis
of OTFG were correctly made in 72.13% (44/61) cases
while 12 (19.67%) cases were misdiagnosed as subserous
myoma, 1 (1.64%) as ovarian malignancy, 2 (3.28%) as
endometrioma, 1 (1.64%) as complex cyst and 1 (1.64%)
as cystadenomas.
Surgery and pathological results
Intraoperative findings revealed 65 tumors in 61 pa-
tients, in which 95.08% (58/61) of the lesions occurred
unilaterally. There were one patient with two lesions
located in the same side and 3 patients within 6 lesions
found bilaterally. In 61 cases, 4/65 (6.15%) tumors were
not identified by ultrasound examination before the sur-
gery. Ascites was found in 20 cases (32.79%) with the
amount of fluid ranging from 50 ml to 800 ml while 1
case showed Megi’s syndrome, i.e., with massive abdom-
inal and pleural effusion. In the 20 cases with ascites,
80% (16/20) of the tumors had a diameter of the tumor
greater than 5 cm. Pearson’s analysis showed a statisti-
cally significant correlation between the diameter of tu-
mors and the amount of ascites fluid (r = 0.50, p < 0.05).
The gross appearances of OTFG neoplasms were de-
scribed as round, oval, lobulated or well-circumscribed
solid tumors. The section of the tumor appeared as gray-
ish white or yellow with edema, cystic degeneration, or
necrosis. Microscopically, the tumor cells were spindle
or short spindle with feather-like or interwoven arrange-
ments. Nucleus of the cell was round or oval, accompan-
ied by calcification, collagen change, and hyalinization
degeneration in the tumors. Final pathologic diagnosis
had 42 thecofibromas (including 3 cellular thecofibro-
mas), 16 fibromas (including 4 cellular fibromas), 5 the-
comas (including 1cellular thecomas), 1 fibrothecoma
and 1 fibrosarcoma. Pathological findings are presented
in Figs. 1 (c), 2 (b, c, d) and 3 (b, c). The Comparison of
ultrasound features and pathological findings were pre-
sented in Table 2.
After surgery, 55 (90.16%) patients were followed up
for an average of 10.6 months from 3 to 72 months.
Postsurgical recurrence was not observed in any cases
(including one patient with fibrosarcoma) by clinical and
sonographic examination. In one patient with Megi’s
syndrome, ascites and pleural effusion disappeared three
months after operation. In addition, two patients had full
term deliveries 1 year after tumor removal.
Discussion
OTFG neoplasms mostly occur in postmenopausal
women, often with a good prognosis. In this study,
63.93% (39/61) of the lesions occurred after menopause,
with 65.57% (40/61) in women aged 51 to 70. Most pa-
tients visited the hospital because of pelvic masses found
in routing physical examination, while 63.93% (39/61) of
these patients showed no obvious clinical symptoms [5].
Symptoms such as abdominal pain and abdominal bulge
may occur in cases with large tumors. Among the 16
patients who visited the hospital for abdominal pain or
bulge, 81.25% (13/16) had a tumor with a diameter over
5 cm. Thecoma is benign lesion and occasionally malig-
nant, which may secrete estrogen and lead to symptoms
such as menstrual disorders and postmenopausal bleed-
ing [14]. Among the sample population,fibromas and
thecofibromas account for 91.80% (56/61) of all tumors
which usually show no postmenopausal bleeding or
menstrual disorders.
The most tumors were unilateral, and few were bilateral
[11]. In our study, surgery revealed that 91.80% (58/61) of
the lesions occurred unilaterally, and 3 cases occurred
bilaterally. In 20 cases (32.79%),minimal and moderate
ascites was present in this study which consistent with
literature reports [15]. Megi’s syndrome occurred in one
case (1/61, 1.64%) in our serial with similar incident rate
by other study [3]. Correlation analysis revealed that the
diameter of tumors was statistically significantly correlated
with CA125 level and the amount of ascites fluid (p <
0.05) which consistent with previous report [16]. Ascites
formation may be due to transudation through the tumor
Table 1 Ultrasound features in 61cases with OTFG neoplasms
Number Percentage (%)
Diameter (cm)
< 5 37 60.66
≥ 5,<10 15 24.59
≥ 10 9 14.75
Echogenicity of the tumor
Hypoechoic 43 70.49
Mixed echoic 17 27.87
Anechoic 1 1.64
Echo attenuation 27 44.26
Doppler flow signal
Score 1: (None) 41 67.21
Score 2: (Minimal) 14 22.95
Score 3: (Moderate) 2 3.28
Score 4: (Abundant) 4 6.56
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surface which exceeds the peritoneum’s resorptive cap-
acity [17]. Irritation of the peritoneal surface by the
tumor may explain the increased CA 125 levels [5].
Pathologically, OTFG neoplasms are tumors of sex-
cord stromal origin and the most of them contain both
theca cells and fibroblasts. Of all tumors identified in
this study, 41/61 (67.21%) tumors were histologically
proved to be thecofibroma. Comparison of ultrasound
and pathologic findings of OTFG indicated that typical
sonographic features of OTFG were adnexal hypoe-
choic masses with clear border and acoustic attenua-
tion,which consistent with previous findings [11, 15].
The sonographic features varied in accordance with
tumor components and degeneration, or complicated
with other cystic lesions [8]. In 4 patients with thecoma
(histologically composed theca cells), ultrasound im-
aging showed uniform hypoechogenic appearance with
attenuation and relatively small in size (less than 5 cm
in diameter), similar to what was found by Eike Burandt
et al. [14]. Pathologically, thecofibroma and fibroma
were described to be more component of fibroblast
and less of theca cells. Therefore, these two types of
tumors showed no dramatic differences on ultrasound
imaging, usually described as adnexal hypoechoic
masses. However, among tumors with a diameter larger
than 5 cm, 95.83% (23/24) of the tumor were diagnosed
as thecofibroma or fibroma; while among tumors with
a diameter larger than 10 cm, 77.79% (7/9) of the
tumor were thecofibroma, with some difference found
by Chung BM et al. [18].
Fig. 1 A 63-year-old woman with pelvic mass was found by physical examination. a A 133 mm*69 mm*169 mm well-circumscribed mixed mass
was detected in the right ovary by ultrasound examination; b ultrasound detected ascites in the pelvis; c pathological findings showed ovarian
thecofibroma with collagen change
Fig. 2 A 53-year-old woman with a pelvic mass discovered by routing physical examination. a On ultrasound examination, a 28 mm*22 mm*26 mm
well-circumscribed hypoechoic mass was observed in the right ovary, with posterior echo attenuation. b On laparoscopy surgery, right ovarian
was hard and enlarged, the surface smooth, having a good mobility; in the pelvic, a small number of pale yellow ascites were observed.
c Pathologically, right ovarian was enlarged, with tough textures and grayish white surfaces. d Pathological findings confirmed thecofibroma
in right ovarian
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Large tumors were often associated with torsion,
hemorrhage, calcification, or complicated with other
cystic lesions, which showed mixed echogenic masses.
In 17 tumors (27.87%) with mixed echogenic appear-
ance, there were 8 thecofibroma, 8 fibroma and 1the-
coma in which all were associated with other
complicated lesions including endometrioma (n = 3),
teratoma (n = 1), cystadenomas (n = 2), 1 case with
hemorrhage (n = 1), ovary torsion (n = 3), calcification
or degeneration changes (n = 7).
Among the 27 tumors that showed acoustic attenu-
ation, 96.30% (26/27) were thecofibroma and fibroma.
The reason of the attenuation is most likely due to the
low sound propagation of fibroblast tissue [19]. In gen-
eral, the blood flow of OTFG tumor is not rich. Minimal
or moderate Doppler flow signals were detected in
26.23% (16/61) tumorsn while 4 (6.56%) tumors showed
abundant flow signals. Therefore, accurate diagnoses can
be made based on sonographic characterizations such as
adrenal hypoechoic masses with clear border, posterior
echo attenuation and minimal or moderate blood flow
signals inside the tumors. In the presence of adnexal
mixed echoic masses, tumor degeneration and with
other tumor should be considers. On the whole, sono-
graphic findings can reflect pathological changes.
In this study, ultrasound examination made correct
diagnosis of OTFG in 44 (72.12%, 44/61) tumors before
surgery. Four tumors less than 2 cm in diameter failed
to be detected by ultrasound, among which 3 cases had
bilateral lesions and 1 case had 2 lesions on the same
side. The detection rate of tumors was 93.85% (61/65).
Failure to detect some tumors may be caused by small
size of the tumors as well as leaving out presence of
contralateral lesions.
In early days with limited understanding of OTFG tu-
mors, it was often confused with subserous myoma on
ultrasound imaging [6]. In the present study, 12 tumors
were misdiagnosed as subserous myoma in patient with
a mean age of 53.57 years and 63.93% postmenopausal
with small ovaries. Based on our experiences, several
techniques can be considered to differentiate OTFG
neoplasms from myoma: 1. uterine myoma often hap-
pened in women of reproductive age instead of postmeno-
pausal women, 2. the myoma’s capsule of connected with
the uterine serosa and with blood supply from uterine
branches, and 3. the masses would be separated from the
uterus with use of manipulation of abdominal compres-
sion. Therefore, a solid mass detected next to the uterus
in postmenopausal woman should not only considerate as
a subserous myoma, in instead of, the OTFG neoplasm
should be ruled out, especially when ipsilateral ovarian is
not displayed.
With technological development, high resolution
ultrasonography and contrast-enhanced ultrasound
imaging have become one of the important imaging
modality for clinical diagnosis and differentiation of
uterine and ovarian neoplasms [20]. A literature review
shows that ovarian fibroma and subserous myoma have
clear differences in contrast-enhanced ultrasound im-
aging. The fibroma showed hypoenhancement with a
delay perfusion of the tumor compared to the uterus
while the subserous myoma exhibited homogeneous
isoenhancement and synchronous enhancement with
the myometrium in early phase [21].
Fig. 3 A 53-year-old pre-menopausal woman having a pelvic mass was detected by physical examination. a On ultrasound examination, a
28 mm*22 mm*26 mm well-demarcated hypoechoic mass with small anechoic areas was observed at left ovary, and moderate Doppler signals
were seen in the tumor; b the tumor section showed grey-white appearance and yellowish areas with hemorrhage in the center of the tumor;
c pathological findings proved to be cellular fibroma with partial growth activity
Table 2 Ultrasound features and pathological findings of the 61 OTFG tumors
Ultrasound features Thecofibroma (n) Fibroma (n) Thecoma (n) Fibrosarcoma (n) Total (n)
Hypoechoic 32 7 3 1 43
Mixed echoic 8 8 1 0 17
Anechoic 1 0 0 0 1
Total 41 15 4 1 61
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In this study, one cellular thecofibroma was misdiag-
nosed as malignancy because it was irregular multilocular
solid tumor with abundant blood flow, which was a sign
of malignancy. Two other misdiagnosed thecofibroma re-
vealed a complex ovarian cyst with homogeneous internal
echoes, which contained a small solid-appearing area with
undetectable flow in it. These two thecofibroma were mis-
diagnosed as endometriomas. These misdiagnosis based
on ultrasound findings were consistent with previous
studies [7, 22, 23].
There are several limitations of the study. First, this is
retrospective research that may lack control and desir-
able study design. Second, all patient’s data is reviewed
and analyzed without blind fashion. Third, the study
only focused on the OTFG neoplasms and did not include
other ovarian tumors for comparison. Further study with
prospective design and comparison with other ovarian
tumors is needed to provide additional information for
differential diagnoses of ovarian tumors.
Conclusion
OTFG neoplasms often occur in postmenopausal women
with no obvious clinical symptoms. Most of them are
benign, with a good prognosis. The typical sonographic
features of OTFG are adnexal hypoechoic masses with
clear border and acoustic attenuation as well as
minimal Doppler flow signals. They are often unilateral
with a diameter smaller than 5 cm. Combined with
clinical information and CA125, ultrasound imaging
could be used as an imaging tool for improving the pre-
operative diagnostic accuracy.
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